NCT02849873

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

Randomized Study Evaluating the Absorption and Systematic Pharmacokinetics of Topically Applied IDP-123 Lotion in Comparison With Tazorac Cream in Subjects With Moderate to Severe Acne Vulgaris Under Maximal Use Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Bausch Health Americas, Inc. · Industry
• Sex: All
• Age: 9 Years
• Healthy volunteers: Not accepted

Summary

The Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison with Tazorac Cream.

Detailed description

Randomized study evaluating the absorption and systematic pharmacokinetics of IDP-123 lotion in comparison with Tazorac Cream in subjects with moderate to severe acne vulgaris under maximal use conditions.

Conditions

• Acne

Interventions

Type	Name	Description
DRUG	IDP-123 Lotion	Lotion
DRUG	Tazorac Cream	Cream

Timeline

• Start date: 2016-06-01
• Primary completion: 2016-12-01
• Completion: 2017-01-01
• First posted: 2016-07-29
• Last updated: 2018-07-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study